Novartis India Ltd

Novartis India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novartis India Ltd

₹ 992 -1.85%
12 Dec 4:00 p.m.
novartis.in BSE: 500672 NSE: NOVARTIND
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Business
The company is primarily engaged in the pharmaceutical business in the area of pain management, organ transplantation, neuroscience, etc. [1]

Website BSE NSE
  • Market Cap ₹ 2,453 Cr.
  • Current Price ₹ 992
  • High / Low ₹ 1,248 / 699
  • Stock P/E 28.1
  • Book Value ₹ 295
  • Dividend Yield 2.52 %
  • ROCE 15.7 %
  • ROE 10.9 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.36 times its book value
  • The company has delivered a poor sales growth of -7.35% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.
  • Earnings include an other income of Rs.53.1 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
104 99 98 121 102 80 76 91 79 85 81 92 87
97 92 93 89 85 73 67 73 62 65 70 68 69
Operating Profit 7 7 6 32 16 8 9 17 17 20 11 24 18
OPM % 7% 7% 6% 26% 16% 10% 12% 19% 21% 23% 14% 26% 21%
6 6 -35 27 7 8 16 12 17 22 10 10 10
Interest 2 1 0 0 0 0 0 0 1 0 0 0 0
Depreciation 3 3 1 1 1 1 2 2 1 0 0 1 1
Profit before tax 9 8 -31 57 21 14 23 28 32 41 21 34 28
Tax % 24% 24% -25% 7% 14% 47% -7% 27% 27% 36% 31% 24% 26%
7 6 -23 52 18 8 25 20 24 27 15 26 20
EPS in Rs 2.84 2.57 -9.47 21.21 7.43 3.08 10.13 8.21 9.59 10.76 5.95 10.42 8.27
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
901 859 870 690 656 564 491 438 381 400 379 335 345
810 861 874 656 631 570 478 426 355 373 314 270 272
Operating Profit 90 -1 -4 34 25 -6 12 12 27 27 65 65 73
OPM % 10% -0% -0% 5% 4% -1% 2% 3% 7% 7% 17% 19% 21%
83 95 101 207 71 172 78 36 33 -17 58 62 53
Interest 0 0 0 0 1 6 2 6 8 5 2 1 1
Depreciation 4 4 4 3 4 3 3 13 12 10 6 3 2
Profit before tax 169 90 93 237 92 158 86 29 40 -4 115 123 124
Tax % 29% -10% 15% 16% 38% 50% 40% 65% 48% -3% 10% 31%
120 99 79 198 57 78 52 10 21 -4 103 85 87
EPS in Rs 37.46 30.83 24.75 62.04 20.33 31.74 20.97 4.08 8.46 -1.51 41.86 34.50 35.40
Dividend Payout % 27% 32% 40% 16% 49% 32% 48% 245% 118% -663% 113% 72%
Compounded Sales Growth
10 Years: -9%
5 Years: -7%
3 Years: -4%
TTM: 6%
Compounded Profit Growth
10 Years: -2%
5 Years: 10%
3 Years: 59%
TTM: 14%
Stock Price CAGR
10 Years: 4%
5 Years: 8%
3 Years: 8%
1 Year: 39%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 10%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 16 16 16 16 14 12 12 12 12 12 12 12 12
Reserves 884 945 986 1,178 906 721 747 708 699 679 763 732 717
0 0 0 0 0 0 0 68 62 24 22 7 6
241 241 244 239 230 377 223 289 229 242 186 173 156
Total Liabilities 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 891
10 8 8 6 6 5 15 76 64 24 19 7 6
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
1,131 1,194 1,238 1,426 1,144 1,106 967 1,001 938 934 964 918 885
Total Assets 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 891

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
7 -5 -60 57 -41 161 -194 -23 -69 39 45 113
-16 22 719 -630 424 69 274 56 95 87 -153 33
-37 -38 -38 -39 -332 -268 -30 -41 -37 -36 -30 -121
Net Cash Flow -46 -20 622 -612 51 -38 50 -9 -11 90 -139 26

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 33 33 35 27 23 28 34 31 37 41 35 45
Inventory Days 108 96 103 92 104 84 111 117 119 117 99 82
Days Payable 117 100 98 89 87 158 168 145 137 148 108 112
Cash Conversion Cycle 24 29 40 30 40 -45 -23 3 19 10 26 15
Working Capital Days 317 353 6 -35 -14 -99 7 9 75 -18 -33 -57
ROCE % 20% 10% 9% 22% 9% 17% 12% 5% 6% 6% 15% 16%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68%
0.09% 0.12% 0.14% 0.17% 0.17% 0.17% 0.23% 0.32% 0.19% 0.19% 0.19% 0.19%
0.78% 0.77% 0.78% 0.77% 0.77% 0.77% 0.75% 0.52% 0.52% 0.52% 0.52% 0.52%
28.46% 28.43% 28.41% 28.37% 28.37% 28.38% 28.34% 28.47% 28.60% 28.61% 28.60% 28.61%
No. of Shareholders 44,64044,37143,99643,27542,62241,94743,34343,99243,12841,23939,26539,596

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports